Biotechnology has been an extremely hot industry thanks to high demand for the sector and new drugs which are boosting revenues across the …
On January 5th, biopharmaceutical company Amgen Inc. (NASDAQ: AMGN) announced plans to collaborate with Kite Pharma (NASDAQ: KITE) on cancer treatments.
In a research report released yesterday, William Blair analyst John Sonnier reaffirmed a Market Perform rating on Amgen Inc. (AMGN) on the heels …